2-Hydroxy-3,5-diisopropylbenzohydrazide, 95.0%, 1g

Thalidomide 4'-oxyacetamide-alkyl-C2-amine (hydrochloride), 100mg

4-(6-Thiophen-2-yl-pyridin-3-yl)-pyrimidin-2-ylamine, 95.0%, 1g

6-Bromo-3-(2-chloro-5-(trifluoromethyl)pyrimidin-4-yl)-1-(phenylsulfonyl)-1H-indole, 97%, 5g

Seproxetine hydrochloride, 98%, 1g

3-(METHOXYCARBONYL)PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

butyl({[4-(propan-2-yl)phenyl]methyl})amine, 95.0%, 1g

2-Acetyl-1-fluoro-1,2-dihydro-3H-1λ3-benzo[d][1,2]iodazol-3-one(AFBI), 98%, 250mg

1-Propanamine, 3-(dibenz[b,e]oxepin-11(6H)-ylidene)-N,N-dimethyl-, hydrochloride (1:1), 98%, 1g

Ethyl 2-formyl 3-oxopropanoate, 95.0%, 10g

(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate, 98%, 1g

Melting crucible ROTILABO® medium high form, 30 ml, 5 Piece(s)

1-methyl-N-[3-(trifluoromethyl)phenyl]-1-hydrazinecarbothioamide, 95%, 5g